In Segment A, individuals will get various doses and schedules of oral ABBV-744 tablet to detect Risk-free dosing program. Extra individuals will be enrolled on the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will probably be supplied as "increase-on" therapy. In Segment C, https://remingtonbpdsl.tokka-blog.com/32168187/5-easy-facts-about-abbv-744-combination-therapy-with-chemotherapy-described